Evidence map›Paper›PMID 33529473›Full record

ArticleAmerican journal of medical genetics. Part A2021

Auditory phenotype of Smith-Lemli-Opitz syndrome.

Christopher K Zalewski, Sarah A Sydlowski, Kelly A King, Simona Bianconi, An Dang Do, Forbes D Porter, Carmen C Brewer

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christopher K ZalewskiNIDCD, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-9196-0589
Sarah A SydlowskiNIDCD, National Institutes of Health, Bethesda, Maryland, USA.
Kelly A KingNIDCD, National Institutes of Health, Bethesda, Maryland, USA.
Simona BianconiNICHD, National Institutes of Health, Bethesda, Maryland, USA.
An Dang DoNICHD, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-4171-0493
Forbes D PorterNICHD, National Institutes of Health, Bethesda, Maryland, USA.
Carmen C BrewerNIDCD, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0003-1462-049X
National Institutes of Health · US

Funding

Clinical Analysis Of Disorders Of Hearing And BalanceZIADC000064 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI HERTZANO, RONNA · 2009 to 2025
$25.2M
Intramural NIH HHS Z99 DC999999
6 · The paper itself

Abstract

Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive multiple congenital malformation and intellectual disability syndrome resulting from variants in DHCR7. Auditory characteristics of persons with SLOS have been described in limited case reports but have not been systematically evaluated. The objective of this study is to describe the auditory phenotype in SLOS. Age- and ability-appropriate hearing evaluations were conducted on 32 patients with SLOS. A subset of 21 had auditory brainstem response testing, from which an auditory neural phenotype is described. Peripheral or retrocochlear auditory dysfunction was observed in at least one ear of 65.6% (21) of the patients in our SLOS cohort. The audiometric phenotype was heterogeneous and included conductive, mixed, and sensorineural hearing loss. The most common presentation was a slight to mild conductive hearing loss, although profound sensorineural hearing loss was also observed. Abnormal auditory brainstem responses indicative of retrocochlear dysfunction were identified in 21.9% of the patients. Many were difficult to test behaviorally and required objective assessment methods to estimate hearing sensitivity. Individuals with SLOS are likely to have hearing loss that may impact communication, including speech and language development. Routine audiologic surveillance should be conducted to ensure prompt management of hearing loss.

Indexed as

Genetic Predisposition to DiseaseAdolescentAdultAudiometryAuditory Diseases, CentralChildChild, PreschoolCochlear NerveEvoked Potentials, Auditory, Brain StemFemaleHearing Loss, SensorineuralHumansInfantMaleMutationOxidoreductases Acting on CH-CH Group Donors7-dehydrocholesterol reductaseOxidoreductases Acting on CH-CH Group Donorsauditoryhearing losssensorineuralSLOSSmith-Lemli-Opitz syndrome

Identifiers

PMID33529473
PMCPMC7994936
OpenAlexW3128117138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.